Cargando…

Alzheimer's disease biomarker discovery using in silico literature mining and clinical validation

BACKGROUND: Alzheimer’s Disease (AD) is the most widespread form of dementia in the elderly but despite progress made in recent years towards a mechanistic understanding, there is still an urgent need for disease modification therapy and for early diagnostic tests. Substantial international efforts...

Descripción completa

Detalles Bibliográficos
Autores principales:	Greco, Ines, Day, Nicola, Riddoch-Contreras, Joanna, Reed, Jane, Soininen, Hilkka, Kłoszewska, Iwona, Tsolaki, Magda, Vellas, Bruno, Spenger, Christian, Mecocci, Patrizia, Wahlund, Lars-Olof, Simmons, Andrew, Barnes, Julie, Lovestone, Simon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3508881/ https://www.ncbi.nlm.nih.gov/pubmed/23113945 http://dx.doi.org/10.1186/1479-5876-10-217

Ejemplares similares

Sensitivity and Specificity of Medial Temporal Lobe Visual Ratings and Multivariate Regional MRI Classification in Alzheimer's Disease
por: Westman, Eric, et al.
Publicado: (2011)

Automated Hippocampal Subfield Measures as Predictors of Conversion from Mild Cognitive Impairment to Alzheimer’s Disease in Two Independent Cohorts
por: Khan, Wasim, et al.
Publicado: (2014)

Application of a MRI based index to longitudinal atrophy change in Alzheimer disease, mild cognitive impairment and healthy older individuals in the AddNeuroMed cohort
por: Aguilar, Carlos, et al.
Publicado: (2014)

The Effect of Age Correction on Multivariate Classification in Alzheimer’s Disease, with a Focus on the Characteristics of Incorrectly and Correctly Classified Subjects
por: Falahati, Farshad, et al.
Publicado: (2015)

Differential Associations of IL-4 With Hippocampal Subfields in Mild Cognitive Impairment and Alzheimer’s Disease
por: Boccardi, Virginia, et al.
Publicado: (2019)

Plasma Biomarkers of Brain Atrophy in Alzheimer's Disease
por: Thambisetty, Madhav, et al.
Publicado: (2011)

Disrupted Network Topology in Patients with Stable and Progressive Mild Cognitive Impairment and Alzheimer's Disease
por: Pereira, Joana B., et al.
Publicado: (2016)

Stability of graph theoretical measures in structural brain networks in Alzheimer’s disease
por: Mårtensson, Gustav, et al.
Publicado: (2018)

Inflammatory Proteins in Plasma Are Associated with Severity of Alzheimer’s Disease
por: Leung, Rufina, et al.
Publicado: (2013)

Education increases reserve against Alzheimer’s disease—evidence from structural MRI analysis
por: Liu, Yawu, et al.
Publicado: (2012)

Predicting Progression of Alzheimer’s Disease Using Ordinal Regression
por: Doyle, Orla M., et al.
Publicado: (2014)

Plasma Based Markers of [(11)C] PiB-PET Brain Amyloid Burden
por: Kiddle, Steven John, et al.
Publicado: (2012)

A Pathway Based Classification Method for Analyzing Gene Expression for Alzheimer’s Disease Diagnosis
por: Voyle, Nicola, et al.
Publicado: (2015)

CERAD Neuropsychological Total Scores Reflect Cortical Thinning in Prodromal Alzheimer's Disease
por: Paajanen, T., et al.
Publicado: (2013)

Genetic Predisposition to Increased Blood Cholesterol and Triglyceride Lipid Levels and Risk of Alzheimer Disease: A Mendelian Randomization Analysis
por: Proitsi, Petroula, et al.
Publicado: (2014)

Deep Sequencing of the Nicastrin Gene in Pooled DNA, the Identification of Genetic Variants That Affect Risk of Alzheimer's Disease
por: Lupton, Michelle K., et al.
Publicado: (2011)

Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer’s disease
por: Whiley, Luke, et al.
Publicado: (2021)

Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer’s Disease
por: Kim, Min, et al.
Publicado: (2017)

Plasma proteins predict conversion to dementia from prodromal disease
por: Hye, Abdul, et al.
Publicado: (2014)

An epigenome-wide association study of Alzheimer's disease blood highlights robust DNA hypermethylation in the HOXB6 gene
por: Roubroeks, Janou A.Y., et al.
Publicado: (2020)

Circulating Proteomic Signatures of Chronological Age
por: Menni, Cristina, et al.
Publicado: (2015)

Random Forest ensembles for detection and prediction of Alzheimer's disease with a good between-cohort robustness()
por: Lebedev, A.V., et al.
Publicado: (2014)

The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease
por: Simrén, Joel, et al.
Publicado: (2021)

A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer’s Disease
por: Khan, Wasim, et al.
Publicado: (2017)

Plasma lipidomics analysis finds long chain cholesteryl esters to be associated with Alzheimer's disease
por: Proitsi, P, et al.
Publicado: (2015)

Urinary metabolic phenotyping for Alzheimer’s disease
por: Kurbatova, Natalja, et al.
Publicado: (2020)

FASTKD2 is associated with memory and hippocampal structure in older adults
por: Ramanan, Vijay K, et al.
Publicado: (2014)

Plasma protein biomarkers of Alzheimer's disease endophenotypes in asymptomatic older twins: early cognitive decline and regional brain volumes
por: Kiddle, S J, et al.
Publicado: (2015)

In vivo (1)H-magnetic resonance spectroscopy can detect metabolic changes in APP/PS1 mice after donepezil treatment
por: Westman, Eric, et al.
Publicado: (2009)

Inflammatory biomarkers in Alzheimer's disease plasma
por: Morgan, Angharad R., et al.
Publicado: (2019)

Association of Peripheral Insulin Resistance and Other Markers of Type 2 Diabetes Mellitus with Brain Amyloid Deposition in Healthy Individuals at Risk of Dementia
por: Pekkala, Timo, et al.
Publicado: (2020)

MicroRNAs Modulate the Pathogenesis of Alzheimer’s Disease: An In Silico Analysis in the Human Brain
por: Gugliandolo, Agnese, et al.
Publicado: (2020)

Is cortisol the key to the pathogenesis of delirium after coronary artery bypass graft surgery?
por: Kazmierski, Jakub, et al.
Publicado: (2011)

Level of Thyroid-Stimulating Hormone (TSH) in Patients with Acute Schizophrenia, Unipolar Depression or Bipolar Disorder
por: Wysokiński, Adam, et al.
Publicado: (2014)

Homocysteine Levels in Patients with Schizophrenia on Clozapine Monotherapy
por: Wysokiński, Adam, et al.
Publicado: (2013)

Hyperphosphorylated tau in young and middle-aged subjects
por: Elobeid, Adila, et al.
Publicado: (2011)

Systems medicine and the integration of bioinformatic tools for the diagnosis of Alzheimer's disease
por: Orešič, Matej, et al.
Publicado: (2010)

Is the subcallosal medial prefrontal cortex a common site of atrophy in Alzheimer's disease and frontotemporal lobar degeneration?
por: Lindberg, Olof, et al.
Publicado: (2012)

Reproducible segmentation of white matter hyperintensities using a new statistical definition
por: Damangir, Soheil, et al.
Publicado: (2016)

Behavioural genetics of Alzheimer's disease: a comprehensive review
por: Flirski, Marcin, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_n3i8q0buhrbrcuvqt4mag8crrq